期刊文献+

吲达帕胺肠溶微球的制备及影响因素考察 被引量:4

Preparation of the Enteric Microspheres of Indapamide and Investigation of the Influencing Factors
原文传递
导出
摘要 目的制备吲达帕胺肠溶微球及影响因素考察。方法以羟丙甲纤维素酞酸酯(HPMCP)为肠溶载体材料,采用乳化溶剂扩散法制备吲达帕胺肠溶微球,对影响微球的成型性、收率、载药量、包封率及其释药性能等因素进行了考察。结果微球形态圆整,架桥剂和乳化剂是其成型主要影响因素;载药量14.85%,包封率76.30%,药物在模拟肠液中累计释放度符合要求,载体材料用量控制药物释放速度。结论本方法适宜制备吲达帕胺肠溶微球,工艺简单,体外肠溶释放性良好。 OBJECTIVE To prepare the enteric microspheres of indapamide and investigate the influencing factors. METHODS Enteric microsphere of indapamide was prepared by emulsion solvent diffusion method using hydroxypropyl methylcellulose phthalate(HPMCP) as an enteric polymer. The formulation of the microspheres, recovery, drug loading, encapsulation efficiency and the releasing characteristic of microspheres in vitro were investigated. RESULTS The microspheres were spherical and smooth in appearance, bridging agent and emulsifying agent were the main factors affecting the formation of microspheres. The drug loading and encapsulation were 14.85% and 76.30%, respectively. The cumulative release of drug in simulated intestinal fluid met the requirements and the amount of carrier material controlled the drug release rate. CONCLUSION This method is suitable for preparation of enteric microspheres of indapamide, the technology is simple and the release characters is good in vitro.
出处 《中国现代应用药学》 CAS CSCD 2012年第11期993-997,共5页 Chinese Journal of Modern Applied Pharmacy
基金 山西省自然科学基金(2008011077-3) 太原市科技创新项目(110148091)
关键词 吲达帕胺 羟丙甲纤维素酞酸酯 肠溶微球 乳化溶剂扩散法 indapamide HPMCP enteric microspheres emulsion solvent diffusion method
  • 相关文献

参考文献5

二级参考文献58

  • 1曹广智,张国全.吲达帕胺在高血压病的临床应用近况[J].综合临床医学,1994,10(5):230-232. 被引量:6
  • 2奚念朱.药剂学[M].北京:人民卫生出版社,1994.232.
  • 3[1]Harkins WD,Gans DM.Monomolecular films,the solid-liquid interface and the sedimentation and flocculation of powders in liquids[J].J Phys Chem,1932,36(1) :86.
  • 4[2]Stock DI.Micro-spherical aggregation of barium sulphate[J].Nature,1952,170:423.
  • 5[3]Smith HM,Puddington IE.Spherical agglomeration of barium sulphate[J].CanJChem,1960,38 (10):1911.
  • 6[4]Kawashima Y,Okumura M,Takenaka H.Spherical crystallization:direct spherical agglomeration of salicylic acid crystals during crystallization[J].Science,1982,216(4):1127.
  • 7[5]Kawashima Y,Aoki S,Takenaka H.Spherical agglomeration of aminophylline crystals during reaction in liquid by the spherical crystallization technique[J].Chem Pharm Bull,1982,30(5):1900.
  • 8[6]Kawashima Y,Naito M,Lin SY,et al.An experimental study of the kinetics of the spherical crystallization of sodium theophylline monohydrate[J].Povder Technol,1983,34(2):255.
  • 9[7]Kawashima Y,Lin SY,Ogawa M,et al.Preparations of agglomerated crystals of polymorphic mixtures and a new complex of indomethacin-epirizole by the spherical crystallization technique[J].J Pharm Sci,1985,74(11):1152.
  • 10[8]Kawashima Y,Handa T,Takeuchi H,et al.Crystal modification of phenytoin with polyethylene glycol for improving mechanical strength,dissolution rate and bioavailability by a spherical crystallization technique[J].Chem Pharm Bull,1986,34(8) :3376.

共引文献75

同被引文献34

  • 1陈聪.吲哒帕胺致低钾血症18例分析[J].中外医学研究,2013,11(20):165-165. 被引量:1
  • 2HOLFER P, JEAN C B, HELMUT S, et al and technical comparison of Sandostatin formulations of long-acting octreotide [J] Notes, 2011, 4:344 Y.
  • 3UN S R, MIN J S, BYUNG H W, et al. Pharmacokinetic LAR and other BMC Research Sustained-release delivery of octreotide from biodegradable polymeric microspheres [J]. AAPS PharrnSciTech, 2011, 12(4): 1293-1301.
  • 4TSENG F G, HUANG H M, CHEN Y F, et al. Simultaneous immobilization protein microarrays by a micro stamper with back-filling reservoir [J]. Sens Actuators B: Chem, 2004, 99(1) 174-185.
  • 5WALLE CF, SHARMA G, RAVI K M. Current approaches to stabilising and analysing proteins during micro-encapsulation in PLGA [J]. Expert Opin Drug Deliv, 2009, 6(2): 177-186.
  • 6Tazri J, Moghal MM, Dewan SM, et al. Formulation and quality determination of indapamide matrix Tablet:a thiazide type antihypertensive drug[J].Advanced Pharmaceutical Bulletin, 2014, 4(2), 191-195.
  • 7Rowe RC,Sheskey PJ, Weller PJ. Handbook of Pharmaceutical Excipients(药用辅料手册)[M].Vol 7. Beijing:Chemical Industry Press, 2005:275-279.
  • 8王知斌, 何仲贵. 吲达帕胺缓释片的研究[D].沈阳药科大学硕士论文, 2001.
  • 9Evans DF, Pye G, Bramley R, et al. Measurement of gastrointestinal pH profiles in normal ambulant human subjects.[J]. Gut, 1988, 29(8):1035-1041.
  • 10蔡涛,王丹,宋志祥,佘万能.微胶囊的制备技术及其应用[J].化工中间体,2009,5(12):6-13. 被引量:9

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部